BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15310467)

  • 1. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
    Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
    Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
    Chen SS; Ferrante AA; Terwilliger EF
    Virology; 1996 Dec; 226(2):260-8. PubMed ID: 8955046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Celada F; Düzgüneş N
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.
    Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K
    Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
    Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    Grimaila RJ; Fuller BA; Rennert PD; Nelson MB; Hammarskjöld ML; Potts B; Murray M; Putney SD; Gray G
    J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.
    Watkins BA; Crowley R; Davis AE; Louie AT; Reitz MS
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2513-22. PubMed ID: 9349472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
    Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
    Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope.
    Sabatier JM; Mabrouk K; Moulard M; Rochat H; Van Rietschoten J; Fenouillet E
    Virology; 1996 Sep; 223(2):406-8. PubMed ID: 8806580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells.
    Ohki K; Kishi Y; Nishino Y; Sumiya M; Kimura T; Goto T; Nakai M; Ikuta K
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1233-40. PubMed ID: 1682474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
    Jiang A; Fisher H; Pomerantz RJ; Dornburg R
    Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverted HIV-1 Mutants in CD4
    Lu W; Li TW; Phillips S; Wu L
    Microbiol Spectr; 2021 Dec; 9(3):e0165321. PubMed ID: 34935422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A; Ladha A; Cohen EA; Menezes J
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the single cycle replication of HIV-1 expressing Gaussia luciferase in human PBMCs, macrophages, and in CD4(+) T cell-grafted nude mouse.
    Ao Z; Huang J; Tan X; Wang X; Tian T; Zhang X; Ouyang Q; Yao X
    J Virol Methods; 2016 Feb; 228():95-102. PubMed ID: 26640121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.
    Bachrach E; Dreja H; Lin YL; Mettling C; Pinet V; Corbeau P; Piechaczyk M
    Virology; 2005 Feb; 332(1):418-29. PubMed ID: 15661172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nef gene controls syncytium formation in primary human lymphocytes and macrophages infected by HIV type 1.
    Meylan PR; Baumgartner M; Ciuffi A; Munoz M; Sahli R
    AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1531-42. PubMed ID: 9840286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.